Financials

	2017	2018
Net sales	2.02Cr 1.81Cr 1.67Cr 1.52Cr 2.84Cr 192.61Cr 2.88Cr 20Cr 7.97Cr 100.74Cr 7.6Cr 7.44Cr 318.98Cr	2.64Cr 2.36Cr 2.18Cr 1.98Cr 3.7Cr 251.15Cr 3.76Cr 26Cr 10Cr 131.36Cr 9.91Cr 9.7Cr 415.92Cr
Net income	-4.93Cr -4.41Cr -4.08Cr -3.69Cr -6.91Cr -469.05Cr -7.02Cr -49Cr -19Cr -245.33Cr -19Cr -18Cr -776.78Cr	-4.59Cr -4.11Cr -3.8Cr -3.44Cr -6.44Cr -436.97Cr -6.54Cr -46Cr -18Cr -228.55Cr -17Cr -17Cr -723.65Cr
Net Debt	1Cr 89.85L 83.13L 75.26L 1.41Cr 96Cr 1.43Cr 10Cr 3.96Cr 50Cr 3.77Cr 3.69Cr 158.32Cr	-73.03L -65.3L -60.42L -54.7L -1.02Cr -69Cr -1.04Cr -7.27Cr -2.88Cr -36Cr -2.74Cr -2.68Cr -115.07Cr

Company Profile

Valeritas Holdings Inc is a United States-based company. The Company provides surgical & medical instruments & apparatus.

Employees

Sector

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-4.76%	-96.52%

30/20/30	Valeritas Holdings, Inc. Went Out of Business	CI
08/20/08	First Amended Combined Joint Liquidation Plan & Disclosure Statement Approved for Valeritas Holdings, Inc.	CI

30/20/30	Valeritas Holdings, Inc. Went Out of Business	CI
08/20/08	First Amended Combined Joint Liquidation Plan & Disclosure Statement Approved for Valeritas Holdings, Inc.	CI
03/20/03	First Motion for Exclusivity Period Extension Approved For Valeritas Holdings, Inc.	CI
21/20/21	First Motion for Exclusivity Period Extension Filed by Valeritas Holdings, Inc.	CI
21/20/21	Combined Disclosure Statement and Liquidation Plan Approved for Solicitation Purpose on Interim Basis for Valeritas Holdings, Inc.	CI
15/20/15	First Amended Combined Joint Liquidation Plan & Disclosure Statement Filed by Valeritas Holdings, Inc.	CI
06/20/06	Combined Joint Liquidation Plan & Disclosure Statement Filed by Valeritas Holdings, Inc.	CI
03/20/03	Valeritas Holdings, Inc. Announces Management Changes	CI
02/20/02	Zealand Pharma A/S completed the acquisition of substantially all assets of Valeritas Holdings, Inc.	CI
20/20/20	Motion for Asset Sale Approved for Valeritas Holdings, Inc.	CI
13/20/13	Final DIP Financing Approved for Valeritas Holdings, Inc.	CI
13/20/13	Notice for Auction Cancellation Filed by Valeritas Holdings, Inc.	CI
06/20/06	Bidding Procedure Approved for Valeritas Holdings, Inc.	CI

03/20/03	VALERITAS HOLDINGS INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
23/20/23	Valeritas : Receives Court Approval of Sale of Business to Zealand Pharma	PU
21/20/21	VALERITAS HOLDINGS INC. : Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20/20/20	Valeritas : Receives Court Approval of Sale of Business to Zealand Pharma	PR
19/20/19	VALERITAS HOLDINGS INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VALERITAS HOLDINGS, INC.	-.--%	-4.76%	-	-	2L
ABBOTT LABORATORIES	+1.14%	-0.01%	-17.32%	+12.09%	18TCr
STRYKER CORPORATION	-0.33%	+3.89%	-19.82%	+18.17%	12TCr
MEDTRONIC PLC	-0.65%	+0.04%	+1.20%	+32.76%	12TCr
ESSILORLUXOTTICA	-3.42%	+13.34%	-44.16%	+3.81%	9.33TCr
CENCORA, INC.	-0.30%	-3.20%	-0.81%	+74.49%	6.32TCr
HOYA CORPORATION	+0.04%	+1.79%	+13.52%	+75.53%	5.57TCr
BECTON, DICKINSON AND COMPANY	-1.27%	+2.42%	+5.68%	-23.16%	5.42TCr
IDEXX LABORATORIES, INC.	+1.75%	+1.76%	-11.02%	+38.17%	4.41TCr
ALCON INC.	+0.03%	+5.88%	-5.17%	-10.31%	3.4TCr
Average	-0.57%	+2.48%	-8.66%	+24.62%	7.58TCr
Weighted average by Cap.	-0.54%	+3.05%	-11.96%	+23.05%